Summary
INTEGRON has a registered holding activity and consists mainly of financial fixed assets; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €120 and a net result of €221,543. Equity is growing by ~51.3% per year across the filed fiscal years. Its solvency ranks better than 5% of 16754 sector peers (fiscal year 2025). The company has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Outside the general model
Holding: general score not applicable
The company has a registered holding activity and financial fixed assets account for more than half of its assets. The general operating-company model is unsuitable for this profile, so we show no financial axes either. Filed figures remain available.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
1 signal. The signal on the left, the evidence on the right.
○neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 20-05-2026, 72 days ahead of the deadline.
NBB · 5 filingsDeviation from the deadline
2025
72 d early
2024
66 d early
2023
28 d early
2022
42 d early
2021
41 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 5 accounts on average 50 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What changed in the latest annual accounts?What changed What held for this company on a given day: board, seat, name?Company as of a date
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Equity
€120▼ 100.0%
2024 · €383,634
Total assets
€1.1m▲ 151%
2024 · €435,597
Net result
€221,543▲ 69.7%
2024 · €130,548
Working capital
-€348,586
2024 · €335,689
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€77,125-€140,811▲ 82.6%€112,926▼ 19.8%€165,406▲ 46.5%€238,916▲ 44.4%
Net result€60,321within the sector's middle half-€108,437within the sector's middle half▲ 79.8%€87,500within the sector's middle half▼ 19.3%€130,548above the sector's middle half▲ 49.2%€221,543above the sector's middle half▲ 69.7%
Equity€59,641below the sector's middle half-€167,278within the sector's middle half▲ 180%€253,945within the sector's middle half▲ 51.8%€383,634above the sector's middle half▲ 51.1%€120below the sector's middle half▼ 100.0%
Total assets€86,673below the sector's middle half-€208,346below the sector's middle half▲ 140%€299,125below the sector's middle half▲ 43.6%€435,597within the sector's middle half▲ 45.6%€1.1mabove the sector's middle half▲ 151%
Debt€27,033-€41,068▲ 51.9%€45,180▲ 10.0%€51,963▲ 15.0%€1.1m▲ 2,004%
Working capital€59,311below the sector's middle half-€167,927within the sector's middle half▲ 183%€252,259within the sector's middle half▲ 50.2%€335,689above the sector's middle half▲ 33.1%-€348,586below the sector's middle half
Solvency68.8%within the sector's middle half-80.3%within the sector's middle half▲ 11.5pp84.9%above the sector's middle half▲ 4.6pp88.1%above the sector's middle half▲ 3.2pp0.0%below the sector's middle half▼ 88.1pp
Current ratio3.19within the sector's middle half-5.17within the sector's middle half▲ 1.986.82above the sector's middle half▲ 1.657.89above the sector's middle half▲ 1.070.53below the sector's middle half▼ 7.37
Return on assets (ROA)69.6%above the sector's middle half-52.0%above the sector's middle half▼ 17.5pp29.3%above the sector's middle half▼ 22.8pp30.0%within the sector's middle half▲ 0.7pp20.3%within the sector's middle half▼ 9.7pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 44% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.1m
Fixed assets
€703,546 ▲ 1,274%
Current assets
€389,766 ▲ 1.4%
Equity and liabilities €1.1m
Equity
€120 ▼ 100.0%
Debt
€1.1m ▲ 2,004%
Debt's share of the balance-sheet total rises from 11.9% to 100.0%. Equity is lower and debt is higher.
Key figures and ratios
Debt ≤ 1 year
€738,352▲
2024 · €48,693
Debt > 1 year
€351,667
Income taxes
€58,406▲
2024 · €38,037
Equity ratios withheld: equity of €120 is too small for a meaningful ratio.
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €3,175 | €182 | €1,043 | €12,338 | €13,479 | ▲ 9.2% |
| Other operating charges640/8 | €844 | €1,265 | €1,578 | €1,689 | €1,969 | ▲ 16.6% |
| Gross operating margin9900 | €81,144 | €142,259 | €115,547 | €179,433 | €254,364 | ▲ 41.8% |
| Operating profit (loss)9901 | €77,125 | €140,811 | €112,926 | €165,406 | €238,916 | ▲ 44.4% |
| Financial income75/76B | €3 | - | €888 | €6,523 | €52,388 | ▲ 703% |
| Recurring financial income75 | €3 | - | €888 | €6,523 | €52,388 | ▲ 703% |
| Financial charges65/66B | €88 | €866 | €1,904 | €3,343 | €11,356 | ▲ 240% |
| Recurring financial charges65 | €88 | €866 | €1,904 | €3,343 | €11,356 | ▲ 240% |
| Profit (loss) for the period before taxes9903 | €77,041 | €139,946 | €111,910 | €168,585 | €279,949 | ▲ 66.1% |
| Income taxes67/77 | €16,720 | €31,508 | €24,409 | €38,037 | €58,406 | ▲ 53.6% |
| Profit (loss) for the period9904 | €60,321 | €108,437 | €87,500 | €130,548 | €221,543 | ▲ 69.7% |
| Profit (loss) for the period to be appropriated9905 | €60,321 | €108,437 | €87,500 | €130,548 | €221,543 | ▲ 69.7% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €86,673 | €208,346 | €299,125 | €435,597 | €1.1m | ▲ 151% |
| Fixed assets21/28 | €330 | €148 | €3,521 | €51,215 | €703,546 | ▲ 1,274% |
| Tangible fixed assets22/27 | €330 | €148 | €3,521 | €51,215 | €37,737 | ▼ 26.3% |
| Plant, machinery and equipment23 | - | - | - | €468 | €351 | ▼ 25.0% |
| Furniture and vehicles24 | €330 | €148 | €3,521 | €50,747 | €37,385 | ▼ 26.3% |
| Financial fixed assets28 | - | - | - | - | €665,810 | - |
| Current assets29/58 | €86,343 | €208,198 | €295,604 | €384,382 | €389,766 | ▲ 1.4% |
| Amounts receivable within one year40/41 | - | - | €3,357 | €7,277 | €6,230 | ▼ 14.4% |
| Other amounts receivable41 | - | - | €3,357 | €7,277 | €6,230 | ▼ 14.4% |
| Current investments50/53 | - | - | €150,000 | €270,000 | - | - |
| Cash at bank and in hand54/58 | €85,265 | €184,420 | €122,069 | €80,160 | €360,187 | ▲ 349% |
| Deferred charges and accrued income490/1 | €1,078 | €23,779 | €20,178 | €26,944 | €23,349 | ▼ 13.3% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €86,673 | €208,346 | €299,125 | €435,597 | €1.1m | ▲ 151% |
| Equity10/15 | €59,641 | €167,278 | €253,945 | €383,634 | €120 | ▼ 100.0% |
| Contributions10/11 | €120 | €120 | €120 | €120 | €120 | = |
| Reserves13 | €59,521 | €167,158 | €253,825 | €383,514 | - | - |
| Distributable reserves133 | €59,521 | €167,158 | €253,825 | €383,514 | - | - |
| Amounts payable17/49 | €27,033 | €41,068 | €45,180 | €51,963 | €1.1m | ▲ 2,004% |
| Amounts payable after more than one year17 | - | - | - | - | €351,667 | - |
| Financial debts170/4 | - | - | - | - | €351,667 | - |
| Amounts payable within one year42/48 | €27,033 | €40,271 | €43,345 | €48,693 | €738,352 | ▲ 1,416% |
| Current portion of amounts payable after more than one year42 | - | - | - | - | €83,000 | - |
| Trade debts44 | €2,397 | €2,492 | €2,547 | €2,747 | €2,420 | ▼ 11.9% |
| Suppliers440/4 | €2,397 | €2,492 | €2,547 | €2,747 | €2,420 | ▼ 11.9% |
| Taxes, remuneration and social security45 | €10,138 | €10,842 | €1,710 | €1,800 | €1,500 | ▼ 16.7% |
| Taxes450/3 | €10,138 | €10,842 | €1,710 | €1,800 | €1,500 | ▼ 16.7% |
| Other amounts payable47/48 | €14,498 | €26,937 | €39,088 | €44,146 | €651,432 | ▲ 1,376% |
| Accrued charges and deferred income492/3 | - | €797 | €1,835 | €3,270 | €3,174 | ▼ 2.9% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €60,321 | €108,437 | €87,500 | €130,548 | €221,543 | ▲ 69.7% |
| + Depreciation and write-downs630 | €3,175 | €182 | €1,043 | €12,338 | €13,479 | ▲ 9.2% |
| Operating cash flow (approximation) | €63,495 | €108,620 | €88,543 | €142,886 | €235,021 | ▲ 64.5% |
| Investment in fixed assets (approximation) | - | €0 | -€4,417 | -€60,032 | -€665,810 | ▼ 1,009% |
| Change in cash | - | €99,154 | -€62,350 | -€41,909 | €280,026 | ▲ 768% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
20-05
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Highest result since 2021net €221,543 ▲69.7%
Operating result €238,916, net result €221,543, both a record.
26-05
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
03-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial
Equity above €200,000Eq €253,945 ▲51.8%
3 profitable years in a row build equity to €253,945.
19-06
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
31-12
Financial
Equity above €150,000Eq €167,278 ▲180%
2 profitable years in a row build equity to €167,278.
20-06
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Dendermonde · 1 establishment unit since 2020
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Em. Hielstraat(DEN)(Afgesch.) 999200 DendermondeGround area
1,320 m²
Building footprint
305 m²
Volume, LiDAR
3,469 m³
Parcel 24432D0096/00Y002, Flanders · tallest building 15.5 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
INTEGRON
since 20202.305.069.297
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24432D0096/00Y002 | Flanders | 1,320 m² | 1 · 305 m² | 15.5 m · 4 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Structure & network
Owners and holdings
1 holdingOwners 0
The accounts to 31-12-2025 list no shareholders, and no other source names one.
Holdings 1
-
33.33%
According to the 2025 annual accounts of INTEGRON and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.
Similar companies · same sector, comparable size
Groepspraktijk Beukenlaan
BE 1001.710.585
Boom · Eq €101
Have A Nice Day Surgery
BE 0541.758.757
Lubbeek · Eq €100
Dr. V. Vervaet
BE 0558.908.357
Destelbergen · Eq €100
Dr. Kurt Buccauw, radiologie
BE 0644.845.607
Oud-Heverlee · Eq €100
DRS. CAEKEBEKE EN D'HAESE
BE 0649.939.095
Kortrijk · Eq €100
Of 16,631 companies in sector 86220 we hold annual accounts for 7,985. 103 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded16-07-2020
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
64210Activities of holding companies
E-invoicing
Reachable via Peppol
Peppol ID
0208:0750772377
Also
9925:BE0750772377
Registered
19-11-2025
Register as of 27 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.